User profiles for Andreea L Stancu
 | Andreea Lucia StancuBrigham Women's Hospital, Harvard Medical School Verified email at bwh.harvard.edu Cited by 488 |
Nanoscale imaging of clinical specimens using pathology-optimized expansion microscopy
Expansion microscopy (ExM), a method for improving the resolution of light microscopy by
physically expanding a specimen, has not been applied to clinical tissue samples. Here we …
physically expanding a specimen, has not been applied to clinical tissue samples. Here we …
[HTML][HTML] Targeted therapies for advanced non-small cell lung cancer
Lung cancer is a serious health problem and the leading cause of cancer death worldwide,
due to its high incidence and mortality. 85% of lung cancers are represented by the non-…
due to its high incidence and mortality. 85% of lung cancers are represented by the non-…
PAM50 molecular intrinsic subtypes in the Nurses' health study cohorts
Background: Modified median and subgroup-specific gene centering are two essential
preprocessing methods to assign breast cancer molecular subtypes by PAM50. We evaluated the …
preprocessing methods to assign breast cancer molecular subtypes by PAM50. We evaluated the …
[HTML][HTML] AMPK activation can delay aging
AL Stancu - Discoveries, 2015 - ncbi.nlm.nih.gov
AMPK controls the regulation of cellular homeostasis, metabolism, resistance to stress, cell
survival and growth, cell death, autophagy, which are some of the most critical determinants …
survival and growth, cell death, autophagy, which are some of the most critical determinants …
Deep learning image analysis of benign breast disease to identify subsequent risk of breast cancer
…, KH Kensler, GM Baker, AL Stancu… - JNCI Cancer …, 2021 - academic.oup.com
Background New biomarkers of risk may improve breast cancer (BC) risk prediction. We
developed a computational pathology method to segment benign breast disease (BBD) whole …
developed a computational pathology method to segment benign breast disease (BBD) whole …
[HTML][HTML] Discoveries: an innovative platform for publishing cutting-edge research discoveries in medicine, biology and chemistry
…, R Nat, C Nucera, A Popa-Wagner, AL Stancu… - Discoveries, 2013 - ncbi.nlm.nih.gov
Discoveries is a new peer-reviewed, open access, online multidisciplinary and integrative
journal publishing high impact reviews, experimental articles, perspective articles, and …
journal publishing high impact reviews, experimental articles, perspective articles, and …
Bortezomib and paclitaxel synergistically induce apoptosis in chronic myelogenous leukemia cells
Bcr-Abl fusion protein plays a critical role in the pathogenesis and progression of Chronic
Myelogenous Leukemia (CML) and in some of the Acute Lymphocytic Leukemia (ALL) cases. …
Myelogenous Leukemia (CML) and in some of the Acute Lymphocytic Leukemia (ALL) cases. …
… Cancer [JNCI Cancer Spectrum, 2021: 5 (1)] Adithya D. Vellal, Korsuk Sirinukunwattan, Kevin H. Kensler, Gabrielle M. Baker, Andreea L. Stancu, Michael E. Pyle …
SJS Collins, JL Connolly, M Veta, AH Eliassen… - …, 2021 - academic.oup.com
Corrigendum Page 1 Corrigendum Corrigendum to: Deep Learning Image Analysis of
Benign Breast Disease to Identify Subsequent Risk of Breast Cancer [JNCI Cancer …
Benign Breast Disease to Identify Subsequent Risk of Breast Cancer [JNCI Cancer …
[HTML][HTML] Thyroid-related adverse events induced by immune checkpoint inhibitors
Immune checkpoint inhibitors, namely anti-CTLA-4, anti-PD-1 and anti-PD-L1 monoclonal
antibodies, have emerged in the last decade as a novel form of cancer treatment, promoting …
antibodies, have emerged in the last decade as a novel form of cancer treatment, promoting …
[HTML][HTML] PLK1 is a binding partner and a negative regulator of FOXO3 tumor suppressor
FOXO family members (FOXOs: FOXO1, FOXO3, FOXO4 and FOXO6) are important
transcription factors and tumor suppressors controlling cell homeostasis and cell fate. They are …
transcription factors and tumor suppressors controlling cell homeostasis and cell fate. They are …
